| Home | Log In | Register | Our Services | My Account | Contact | Help |
You are NOT currently logged in
Register now or login to post to this thread.
MELDEX. Double your money- quicktime. (MDX)
kitosdad
- 12 Dec 2007 16:20
The engines have fired up at last for MDX. ( BPRG ) At long last they are being recognised for the force they will become over the next two years. On the cusp of disclosing huge revenue-earning deals with Global pharmacists. These have been hinted at as being unrolled before the years end, but may be in the next days.You still have time to get in at a bargain-basement price before the SP takes off for real shortly.
tabasco - 23 Sep 2008 10:29 - 2834 of 8631
I didnt think I was that rude Dil? Just having a Giraffe! lol
tabasco - 23 Sep 2008 16:05 - 2835 of 8631
B J Muncaster - 23 Sep'08 - 13:55
Look, in attempt to cut down on the number of posts talking about what we want to see in the interim statement here's a copy of a note I sent early this month to someone who does have influence; at least I think so! This note set out what I want to see in the statement and I hope I've made my point.
----------------------------------------------------------------------------
The interim statement is an opportunity to stop the incessant emails, abuse, phone calls and other time wasting activities generated by the PIs who, to be fair to them, feel disenfranchised in terms of meaningful information.
We do not need a chemistry lesson. So any description or comment about specific products should be couched in simple to understand language with more complex details made available on the website.
Key points for clarification:
Cash:
Shareholders and the market at large have no idea about the ability of the Company to meet its working capital requirements for the next twelve months. This uncertainty is the main reason for the lack of buying.
Given the growth in revenues and the requirement to build inventory to service sales and resources to finance debtors, nobody expects the Company to be sitting on a pile of cash. But if cash is relatively tight and no comment is made about access to cash, either by a standby facility or factoring, then the market will think a cheap fundraising is on the immediate horizon. So its extremely important to spell out precisely how the Company is meeting and plans to meet its cash flow needs.
Sales:
We know sales revenue is derived from a broad range of products; around 155 different ones the last time I heard. 155 is too big a number to warrant details about each product, and thats OK. But what is needed is very clear details about the market reach and sales generated from the following high profile lines (all subject of bullish RNSs over the last twelve months):
SCP/NRT
TabWrap/FastWrap analgesic tablets
Rocgel
Daosin
Plus, of course, any other products that produce a significant chunk of the revenues.
PIs have not forgotten about RTs comments over a year ago about a major film supply contract for a customer in the US expected to generate $5-6M p.a.. What happened/is happening to this?
Royalty/fee income:
Its no longer acceptable to mention royalty or fee income without providing actual numbers. The term Significant royalties (as was the case when referring to the first receipt from FMC) is meaningless in todays market. Tell us what the number is and well decide if its significant to our investment. Same goes for any development fee income; obviously wed like to know the source of any fees, but if disclosure of the payee is restricted by NDA then say so.
Partner Programmes/deals:
Again, its no longer acceptable to just refer to some of the worlds leading pharma companies. Most other companies having deals with pharma partners are quite capable of mentioning the name of the partner, and when I was running BPRG I was able to announce deals with P&G, Bristol Myers, Wyeth, Nestle, Boots, Perrigo, FMC, Convatec and so on and so forth, all large corporations. So I do not accept for one minute that the Company is unable to name names.
FMC readily answer questions about the progress of NRobe and its Chairman has no problem referring to it in bullish terms in his annual report. Yet aside from the earlier comment about royalties we hear nothing from MDX about its progress and prospects. If FMC meets its minimum obligation under the agreement I negotiated (I know RT made some changes to this, and I dont know what the changes were), then the probable income from FMC would go a long way to underpinning the Companys current market cap all by itself.
Kit:
How many TabWrap and other machines do we have and where are they? If some, e.g. the Meltums machine are just prototype stage, then say so. We can live with accurate information!
Management:
Obviously we need a steer about the planned make-up of the executive team post RT.
Its time the Company had a full-time internal bod responsible for communications. Currently it seems as though the job is handled by anyone and everyone on a low priority basis. The web-site is a shambles (even the copyright is still 2007!), RNSs are inconsistent, often wrong requiring amendments and usually full of typos. We need one person to own the function; Im sure youd welcome that as it would make your job much easier.
Terminology:
We really must have a clear definition of launch. I know RT had a go at it last year, but its meaning is still not clear in PIs minds. We could do with a chart on the website showing:
Product name
Its status i.e. where is it in the following chain - development, trials, pre-production, production, distribution, retail.
Its availability i.e. territories where it can be purchased.
Look, in attempt to cut down on the number of posts talking about what we want to see in the interim statement here's a copy of a note I sent early this month to someone who does have influence; at least I think so! This note set out what I want to see in the statement and I hope I've made my point.
----------------------------------------------------------------------------
The interim statement is an opportunity to stop the incessant emails, abuse, phone calls and other time wasting activities generated by the PIs who, to be fair to them, feel disenfranchised in terms of meaningful information.
We do not need a chemistry lesson. So any description or comment about specific products should be couched in simple to understand language with more complex details made available on the website.
Key points for clarification:
Cash:
Shareholders and the market at large have no idea about the ability of the Company to meet its working capital requirements for the next twelve months. This uncertainty is the main reason for the lack of buying.
Given the growth in revenues and the requirement to build inventory to service sales and resources to finance debtors, nobody expects the Company to be sitting on a pile of cash. But if cash is relatively tight and no comment is made about access to cash, either by a standby facility or factoring, then the market will think a cheap fundraising is on the immediate horizon. So its extremely important to spell out precisely how the Company is meeting and plans to meet its cash flow needs.
Sales:
We know sales revenue is derived from a broad range of products; around 155 different ones the last time I heard. 155 is too big a number to warrant details about each product, and thats OK. But what is needed is very clear details about the market reach and sales generated from the following high profile lines (all subject of bullish RNSs over the last twelve months):
SCP/NRT
TabWrap/FastWrap analgesic tablets
Rocgel
Daosin
Plus, of course, any other products that produce a significant chunk of the revenues.
PIs have not forgotten about RTs comments over a year ago about a major film supply contract for a customer in the US expected to generate $5-6M p.a.. What happened/is happening to this?
Royalty/fee income:
Its no longer acceptable to mention royalty or fee income without providing actual numbers. The term Significant royalties (as was the case when referring to the first receipt from FMC) is meaningless in todays market. Tell us what the number is and well decide if its significant to our investment. Same goes for any development fee income; obviously wed like to know the source of any fees, but if disclosure of the payee is restricted by NDA then say so.
Partner Programmes/deals:
Again, its no longer acceptable to just refer to some of the worlds leading pharma companies. Most other companies having deals with pharma partners are quite capable of mentioning the name of the partner, and when I was running BPRG I was able to announce deals with P&G, Bristol Myers, Wyeth, Nestle, Boots, Perrigo, FMC, Convatec and so on and so forth, all large corporations. So I do not accept for one minute that the Company is unable to name names.
FMC readily answer questions about the progress of NRobe and its Chairman has no problem referring to it in bullish terms in his annual report. Yet aside from the earlier comment about royalties we hear nothing from MDX about its progress and prospects. If FMC meets its minimum obligation under the agreement I negotiated (I know RT made some changes to this, and I dont know what the changes were), then the probable income from FMC would go a long way to underpinning the Companys current market cap all by itself.
Kit:
How many TabWrap and other machines do we have and where are they? If some, e.g. the Meltums machine are just prototype stage, then say so. We can live with accurate information!
Management:
Obviously we need a steer about the planned make-up of the executive team post RT.
Its time the Company had a full-time internal bod responsible for communications. Currently it seems as though the job is handled by anyone and everyone on a low priority basis. The web-site is a shambles (even the copyright is still 2007!), RNSs are inconsistent, often wrong requiring amendments and usually full of typos. We need one person to own the function; Im sure youd welcome that as it would make your job much easier.
Terminology:
We really must have a clear definition of launch. I know RT had a go at it last year, but its meaning is still not clear in PIs minds. We could do with a chart on the website showing:
Product name
Its status i.e. where is it in the following chain - development, trials, pre-production, production, distribution, retail.
Its availability i.e. territories where it can be purchased.
ptholden
- 23 Sep 2008 16:38
- 2836 of 8631
Who cares what some muppet posts on t'other side? A 50% rise in the SP leading up to or post results gets the SP back to 36p. 50% rise likely? I think not, no run up so far by the rampers, which perhaps means reality has at last sunk in after 5 years of hype. For once I agree with Tabbytwat, I would expect turnover to be in line with the figures recently released, anthing less and MDX will get slaughtered. Where I do expect there to be a significant problem is the net profit, I think the astronomical increase in energy and associated costs will reduce the profit margin substantially. Sub 20p on the cards.
Treblewide
- 23 Sep 2008 17:01
- 2837 of 8631
what a mut
tabasco - 23 Sep 2008 17:08 - 2838 of 8631
(-----------------------------------------------------------------------------)
How wide?
How wide?
Dil
- 23 Sep 2008 17:25
- 2839 of 8631
If that bloody smart arse BJM knew what the fcuk he was talking about then he wouldn't have got booted out himself. He imo was the stupid git who ramped the share price to heaven based on uck all of any substance.
Treblewide
- 23 Sep 2008 17:32
- 2840 of 8631
wide enough...how much are you loosing on this mut?
what is your average price? ....50% down?
what is your average price? ....50% down?
tabasco - 23 Sep 2008 17:35 - 2841 of 8631
Just a snapshot of your wisdom sorry Norman Wisdom!Mr Popular!
Treblewide - 25 Aug 2008 09:48 - 821 of 852
not having a laugh at all...i will be shorting them if they ever got to 8p......i will post up my trade if you like.
Treblewide - 25 Aug 2008 18:34 - 830 of 852
i am going no where i am afraid
Treblewide - 01 Sep 2008 00:48 - 850 of 852
wow training courses....thanks for posting Mick.....
Minder - 01 Sep 2008 12:31 - 853 of 855
So why not save your breath and come back after you have shorted at 8p.
It seems you are just baiting banjomick here. No-one is forcing you to read this site or agree with what is posted here, I think banjomick has explained that this is mainly for his and others use to find out up to date information re MDW. Therefore it follows banjomick will update with website updates, RNSs and anything else he discovers if you don't like that or find it of no value, then don't read it.
Treblewide - 01 Sep 2008 12:53 - 854 of 855
thanks for that minder......great post
Treblewide - 08 Sep 2008 10:45 - 2755 of 2756
just added this to potential short list
Treblewide - 09 Sep 2008 11:16 - 878 of 878
5p bid by end of day
Your name represent the magnitude of your mouth? Doing much karaoke lately? Now piss off and upset some other poor sod! Probably poor old Mick.
Treblewide - 25 Aug 2008 09:48 - 821 of 852
not having a laugh at all...i will be shorting them if they ever got to 8p......i will post up my trade if you like.
Treblewide - 25 Aug 2008 18:34 - 830 of 852
i am going no where i am afraid
Treblewide - 01 Sep 2008 00:48 - 850 of 852
wow training courses....thanks for posting Mick.....
Minder - 01 Sep 2008 12:31 - 853 of 855
So why not save your breath and come back after you have shorted at 8p.
It seems you are just baiting banjomick here. No-one is forcing you to read this site or agree with what is posted here, I think banjomick has explained that this is mainly for his and others use to find out up to date information re MDW. Therefore it follows banjomick will update with website updates, RNSs and anything else he discovers if you don't like that or find it of no value, then don't read it.
Treblewide - 01 Sep 2008 12:53 - 854 of 855
thanks for that minder......great post
Treblewide - 08 Sep 2008 10:45 - 2755 of 2756
just added this to potential short list
Treblewide - 09 Sep 2008 11:16 - 878 of 878
5p bid by end of day
Your name represent the magnitude of your mouth? Doing much karaoke lately? Now piss off and upset some other poor sod! Probably poor old Mick.
Treblewide
- 23 Sep 2008 17:48
- 2842 of 8631
thanks for that...i am aware of what i posted...but thanks for posting anyway.
you seem a bit touchy...so now back tp the question...how much have you lost so far?
you seem a bit touchy...so now back tp the question...how much have you lost so far?
tabasco - 23 Sep 2008 18:03 - 2843 of 8631
Thanks for your concernbut I will manage without itscrape bywhy on earth would you go round all these sites and tell people they have invested in sh*te.oh yesof course..now piss off with your mate.. gay boy potty.and do your duet!. Im just drinking to that!
Treblewide
- 23 Sep 2008 18:04
- 2844 of 8631
oh tabasco...do you need a cuddle?...come on come here i will give you a cuddle
Treblewide
- 23 Sep 2008 18:19
- 2845 of 8631
do you want to go behind the bike sheds tobasco? you can feel my bum
Big Al
- 23 Sep 2008 18:32
- 2846 of 8631
Aha, Tabatha is back. The standard of this thread instantly plummeted, which followed the share price.
ptholden
- 23 Sep 2008 19:51
- 2847 of 8631
He's such a tonic and clearly an expert, pity we've never seen any of his own research, just copy and pastes of the bitter and twisted ramblings of the BPRG has been.
tabasco - 24 Sep 2008 08:38 - 2848 of 8631
A very good morning to all mdx investorsto all the others that post on this siteyour wasting your time...revenues projected for /08 50-60 million profit 8+ tab wrap technology now being appliedthe growth of the companies pipeline hard to keep up with.but SP fighting against those that have the shares vs those that want themI have a good six figure investment with this company and know many mdx PIs that also have that commitment+ the market crisis disguises the manipulationalso drawing a direct comparison against many ftse100 companies from the beginning of the year you will find even at these levels it is mostly market trend!
This is what I own for my 41p shares you could own the same for 24p or would you rather move into financials or housing or retail or Ladbrokes and shorting is a dieing tradeI know what my best hedge would be.
Updated R&D pipeline
Product Therapeutic area Technology Development Pre-registration Launch Comments
Rx
DBP117 Migraine Soluleaves 2009/10 Bioequivalence study expected H1 08
DBP118 Anti-emesis Oradisc 2010 Clinicals in 2008, file using 505(b)(2)
DBP149 Oral pain Oradisc 2009 Filed in the UK end Nov 07, will go through MRP
DBP167 Breakthrough pain Solupol 2008/09 Filing in UK expected H2 07, US some time in 08
DBP192 Terminal agitation Solupol 2010 Still early stage development
DBP214 Antihistamine Soluleaves 2007 Accuhist Ultra Soluleaves
DBP215 Cough and cold Soluleaves 2007 Ah-Chew Ultra Soluleaves
DBP220 Pain Paediatric Solupol 2009 Filing H1 2008 with launch 2009
DBP222 Migraine Adult Solupol 2009 Filing H1 2008 with launch 2009
DBP224 Breakthrough pain TabWrap/FastWrap 2010 Filing H2 2008 launch expected 2010
DBP226 Pain Nrobe 2010 Filing H2 2008 launch expected 2010
DBP228 Pain Meltums 2011 Filing H1 2009 launch expected 2011
DBP230 Flu symptoms Sachet 2010 Filing H2 2008 launch expected 2010
DBP232 Flu symptoms TabWrap/FastWrap 2010 Filing H2 2008 launch expected 2010
OTC
DBP121 Smoking cessation Soluleaves 2009 PK studies with known comparators H1 08
To be launched in early 2008 in unregulated markets
DBP122 Smoking cessation Meltums 2009 Chewable lozenge
To be launched in early 2009 in unregulated markets
DBP130 Anti-diarrhoea Soluleaves 2010
DBP147 Local anaesthetic Soluleaves 2007 Launched in US, Filing expected H1 08 in EU under Collunovar brand
DBP211 Decongestant Soluleaves 2007 Launched in US, Filing expected H1 08 in EU.
DBP213 Cough suppressant Soluleaves 2007 Launched in US, Filing expected H1 08 in EU.
DBP216 Analgesic TabWrap 2007 Will launch in US end 2007
DBP240 Analgesic TabWrap 2007 Will launch in Germany end 2007
DBP241 Analgesic FastWrap 2009/10 Talking to possible global partners
DBP272 Gastric Reflux Solupol 2008 (EU) Combination product with antacid
DBP274 Gastric Reflux Solupol 2009 Liquid raft alone
DBP276 Gastric Reflux Solupol 2009 Chewable version of combination product
DBP278 Gastric Reflux Solupol 2009 Chewable version of liquid raft
DBP310 Analgesic FastWrap 2008/09 Will file H2 08 in EU - Launch US H2 08
DBP312 Analgesic TabWrap/FastWrap 2009 Analgesic with codeine. Will file H2 08
DBP314 Analgesic FastWrap 2008/09 With phenylephrine. Will file H2 08 in EU, Launch US H2 08
DBP350 Analgesic XLWrap 2009 Sustained release analgesic - filing H2 2008 EU
DBP351 Analgesic XLWrap 2009 Sustained release analgesic - filing H2 2008 EU
DBP352 Analgesic XLWrap 2009 Sustained release analgesic - filing H2 2008 EU
DBP355 Analgesic TabWrap 2009 Novel Analgesic/NSAID combination - filing H2 2008 Global
DBP356 Analgesic TabWrap 2009 Novel Analgesic/NSAID combination - filing H2 2008 Global
Co-development with partner
Development Programmes
DBP117 Anti-Migraine Soluleaves Prescription - revenues expected from deals early 2008, 3% of Triptan market c.f. 1-1.5% of $3.1bn market
DBP118 - Anti-emesis Oradisc Prescription
DBP121 Smoking Cessation Product Soluleaves
DBP121 - Smoking cessation Soluleaves 2009 PK studies with known comparators H1 08 [Delayed was PK studies H2 07] [OTC]
DBP122 Smoking cessation Meltums 2009 Chewable lozenge
DBP130 - Anti-Diarrhoea Soluleaves Pre-registration
DBP147 Local anaesthetic Soluleaves 2007 Launched in US, Filing expected H1 08 in EU under Collunovar brand
DBP149 - Oral pain Oradisc 2009 Filed in the UK end Nov 07, will go through MRP [New] [RX] (Benzocaine containing a bio-erodible patch)
DBP167 Breakthrough pain Solupol 2008/09 Filing in UK expected H2 07, US some time in 08
DBP192 Terminal agitation Solupol 2010 Still early stage development
DBP211 Decongestant Soluleaves 2007 Launched in US, Filing expected H1 08 in EU.
DBP213 Cough suppressant Soluleaves 2007 Launched in US, Filing expected H1 08 in EU.
DBP214 - Antihistamine Soluleaves 2007 Accuhist Ultra Soluleaves [Now Rx]
DBP215 - Cough and cold Soluleaves 2007 Ah-Chew Ultra Soluleaves USA [Now Rx]
DBP216 - Analgesic (Paracetamol) TabWrap Scale Up - (Germany, Gesine Launch 2008), Will launch in US end 2007
DBP220 - Pain Paediatric Solupol 2009 Filing H1 2008 with launch 2009 - To be launched in early 2008 in unregulated markets
DBP222 - Migraine Adult Solupol 2009 Filing H1 2008 with launch 2009 [Bought forward was 2011]
DBP224 - Breakthrough pain TabWrap/FastWrap 2010 Filing H2 2008 [launch expected 2010 Bought forward was 2011]
DBP226 - Pain Nrobe 2010 Filing H2 2008 launch expected 2010 [Bought forward was 2011]
DBP228 - Pain Meltums
DBP230 - Flu symptoms Sachet 2010 Filing H2 2008 [launch expected 2010 Bought forward was 2011]
DBP232 - Flu symptoms TabWrap/FastWrap 2010 Filing H2 2008 [launch expected 2010 Bought forward was 2011]
DBP240 - Tabwrap, Pain Relief - Ibuprofen (Germany, Gesine Launch) - 1000 pharmacies with Gesine and other groups [OTC], Will launch in Germany end 2007
DBP241 - Tabwrap/Fastwrap, Pain Relief (v. of DBP240, Performs significantly better than expected - gbl. partners,2009/10) [OTC]
DBP272 - Gastric Reflux Solupol 2008 (EU) Rocgel - Combo product with antacid. Partner product [OTC]
DBP274 - Gastric Reflux - Basic RocGel Global 2008/9 - Extension of territorial rights
DBP276 - Gastric Reflux - Chewable / Solupol??? RocGel Global 2008/9
DBP278 - Gastric reflux Solupol
DBP310 - Analgesic (DBP216 deriv, parcetamol) - basic FastWrap (Paracetamol) - Acc dev, Will file H2 08 in EU - Launch US H2 08
DBP312 - Analgesic - combo FastWrap (Paracetamol with decongestant)- With codeine? - Acc dev, Will file H2 08
DBP314 - Analgesic (DBP216 deriv, paracetamol) Cold & flu, with phenylephrine? FastWrap- [OTC] Acc dev, Will file H2 08 in EU, Launch US H2 08
DBP316 - Paracetamol (DBP216 deriv, paracetamol) with decongestant + antihistamine
DBP318 - Paracetamol (DBP216 deriv, paracetamol) with decongestant + cough suppressant
DBP320 - Non-Drowsy Day (DBP216 deriv, paracetamol) - Night Cold & Flu Combination
DBP350 - Analgesic XLWrap 2009 Sustained release analgesic - filing H2 2008 EU [OTC]
DBP351 - Analgesic XLWrap 2009 Sustained release analgesic - filing H2 2008 EU [OTC]
DBP352 - Analgesic XLWrap 2009 Sustained release analgesic - filing H2 2008 EU [OTC]
DBP355 - Analgesic TabWrap 2009 Novel Analgesic/NSAID combo - filing H2 2008 Global [partner product] [OTC]
DBP356 - Analgesic TabWrap 2009 Novel Analgesic/NSAID combo - filing H2 2008 Global [partner product] [OTC]
DBP404 - Modified DBP216, Paediatric, easy swallow, low dose tablet, rapid release.
DBP??? - Tabwrap - obesity - License agreement
DBP??? - Meltums - 3 Products for the treatment of Dementia and Alzheimers - License agreement
DBP??? - Meltums - novel nicotine-containing product ???
........
Current Products and known launched products.
Dexo - Hyposalix - Artificial saliva.
Dexo US - Ah Chew Suspension - 12-Hour Dosing for Sinusitus and Common Cold - http://www.dexous.com/ah_chew_suspension.asp
Dexo US - Ah Chew D Suspension
Dexo US - Ah Chew Syrup
Dexo US - Ah Chew Ultra Suspension
Dexo US - Ah Chew Ultra Tablets - Chewable, Allergic Rhinitis and Post-Nasal Drip Relief - http://www.dexous.com/ah_chew_ultra.asp
Dexo US - Dexodryl Chewable Tablets - Antihistamine - Drying Agent - http://www.dexous.com/dexodryl_tabs.asp
Dexo US - Dexodryl Suspension - Antihistamine - Drying Agent - http://www.dexous.com/dexodryl_susp.asp
Dexo US - EZ Spacer - http://www.dexous.com/ez_spacer.asp
Dexo US - EZ Spacer PedsPak - http://www.dexous.com/ez_spacer_peds_pak.asp
Dexo US - Omnihist II LA - Antihistamine/Decongestant Tablet with Drying Agent - http://www.dexous.com/omnihist_ii_la.asp
Dexo US - Sinutuss DM Tablets - Three way Sinusitis and Bronchitis relief- http://www.dexous.com/pdf/sinu_tuss_dm.pdf
Dexo US - Sinuvent PE - Decongestant and expectorant tablet - http://www.dexous.com/sinuvent_pe.asp
Dexo US - SymPak - Sinuvent/ Omnihist AM/PM Dose format - Cough and Cold - http://www.dexous.com/pdf/SymPak.pdf
Dexo US - SymPak PDX - Sinuvent/ Omnihist AM/PM Dose - Cough and Cold - Extended Relief - http://www.dexous.com/pdf/SymPak.pdf
Dexo France - Artisial
Dexo France - BI OROSTAL (Added 09.08.07)
Dexo France - CITRATE BETAINE
Dexo France - CLERIDIUM
Dexo France - Collunovar
Dexo France - CORTISAL
Dexo France - Dexef
Dexo France - Diacor
Dexo France - DIMEGAN
Dexo France - ELIXIR BONJEAN
Dexo France - Endium
EXTOVYL 12mg G gra Fl/60 (3225099)
HYDRALOR Pdr sbuv rydrat 10Sach/5,2g (7934674)
Dexo France - Inflaced
Dexo France - Magnespasmyl
Dexo France - MUCIPULGITE
Dexo France - MULKINE
Dexo France - NITRODEX CHRONULES
Dexo France - Ronflux - Nasal Spray - EU registered for Ronflux Nasal Spray as a medical device - partnering in EU and worlwide
Dexo France - Ronflux - Strip
Dexo France - Ronflux - Mouth Spray line extension (In development)
Dexo France - Trolovol
Dexo France - Rogel
Dexo France - SPIRONONE
Dexo France - Physiomycine
Dexo Italy - Ceporex
Dexo Italy - Tamoxifen
Dexo Italy - Gabbroral
Dexo Italy - Acyvir
Dexo Italy - Curoxim
Dexo Italy - Eusaprim
Dexo Italy - Lefcar
Dexo Italy - Flutamide
Dexo Italy - Semprex
Dexo Italy - Atox - Liver detoxicant - licensed from AD Pharma
Dexo Italy - Antiserol - Cholesterol - licensed from AD Pharma
Dexo Italy - Floract - Intestinal Flora - licensed from AD Pharma
Dexo Italy - (From Dexo France) Hypozalix - Artificial saliva
Dexo Italy - (From Dexo France) Ronflux - Snoring
Dexo Italy - (From Dexo France) Calme - Seratonin
Dexo Italy - (From Dexo France) Gel Circulatoire - Muscle cramps/rhenatic pains
Dexo GmBH Germany - DBP240, an ibuprofen TabWrap(TM) analgesic, being launched via Gesine + other pharmacy chains
Dexo GmBH Germany - DMP404, variant of paracetamol aimed specifically for the junior market, 2008 launch
Dexo BioGenerics - Crescent Pharma and Dexo BioPharm, anti depressants one of which is a melt-in-the-mouth version. Sales for these products are
anticipated to commence in Q1 2009. The UK market is estimated to be worth approximately 50m."
Dexo Products - Crescent deal (Niplad's find).
Aluminium Hydroxlde Tablets - (Marketing Authorization from Crescent Pharma)
Aspirin Dispersible Tablets - (Marketing Authorization from Crescent Pharma)
Captopril Tablets - (Marketing Authorization from Crescent Pharma)
Cold and Influenza Capsules - (Marketing Authorization from Crescent Pharma)
Mentholated Balsam Llnctus - (Marketing Authorization from Crescent Pharma)
2 Paracetamol and caffeine capsules - (Marketing Authorization from Crescent Pharma)
Propranolol Tablels lOmg - (Marketing Authorization from Crescent Pharma)
Ibuprofen Tablets - Dossier Data (From Crescent Pharma)
Paracetamol Tablets - Dossier Data (From Crescent Pharma)
Codeine Tablets - Dossier Data (From Crescent Pharma)
Dlphenhydramine Tablets - Dossier Data (From Crescent Pharma)
Amoxicillin Capsules(for use excluding UK) - Dossier Data (From Crescent Pharma)
Amoxicillin Syrup (for use excluding UK) - Dossier Data (From Crescent Pharma)
Flucloxacillin Capsules (for use excluding UK) - Dossier Data (From Crescent Pharma)
Flucloxacillin Syrup (for use excluding UK) - Dossier Data (From Crescent Pharma)
Melbrosin (Own Products)
Melbrosin - menoflavon - menoflavon is a food supplement containing 40 mg isoflavones derived from standardised red clover extract.
Melbrosin - menoflavon forte -menoflavon forte, food supplement, isoflavones, red clover extract.
Melbrosin - menoflavon osteo - menoflavon osteo, food supplement, isoflavones, Calcium, Vitamin D3, Magnesium, Copper and Zinc.
Melbrosin - melbrosia -melbrosia - amino acids, oligopeptids, enzymes and flavonoids.
Melbrosin - melprotect propolis - care and protection of V-zone.
Melbrosin - melpromen - The bee products contained in melpromen - combination of potent topical agents, vitamins, and nutrients
Melbrosin - melpromen with Ginseng
Melbrosin - androflavon - androflavon, dietetic food containing red clover extract, selenium, vitamin E and vitamin D3.
Melbrosin - melbrodent Propolis-Gel - melbrodent Propolis-Gel, inflammation and infections of gums and mucous membranes.
Melbrosin - melbrodent Propolis Toothpaste - melbrodent Propolis Toothpaste, antibacterial.
Melbrosin - melbrosept Propolis Tincture & Spray - melbrosept Propolis Tincture & Spray - spray, drops, mouthwash or skin tonic.
Melbrosin - melbroderm - melbroderm propolis salve has anti-inflammatory and anti-rheumatic effects.
Melbrosin - Phytosulin - Insulin resistance - New product
Melbrosin - DAOsin(R) - Histamine intolerance - New Product
(Distribution Products)
Melbrosin - Imedeen is an unique top-quality skin care product
Melbrosin - SlimCup - SlimCup is a new and innovative concept for nutrition and weight management. New flavours, Feb 2008
Melbrosin - Botoina -Botoina is a special cosmetic for the relaxation of facial wrikles
Melbrosin - Crescina
Melbrosin - Labo
Melbrosin - Ladival - Individual sun protection and care for every one.
Melbrosin - Grippostad - cold symptoms such as headache, temperature and coughs.
Melbrosin - marplus -A nose spray for dry, sensitive and running noses.
Melbrosin - Bilatin -Bilatin Omega-3 fish oil capsules, arteriosclerosis, cholesterol regulation, rheumatism, heart attacks.
Melbrosin - Bilatin forte -Bilatin forte omega-3 fish oil capsules with pure natural fish oil.
Melbrosin - AciclostadMelbrosin - Aciclostad herpes cream 2g, active ingredient Aciclovir.
Melbrosin - Apotheker's Echte Hustenbonbons - High quality cough drops.
Melbrosin - Wellness line - Products for well being
Melbrosin - Etocovit - Capsules with natural Vitamin E
Melbrosin - Selamin - Tablets containing selenium
Melbrosin - Selamin plus - A combination of selenium and copper
Melbrosin - Melbrosin - Selamin-E - A combination of selenium and vitamin E
Melbrosin - Melbrosin - Sinusol - for cattarhal affections of the respiratory tract
Melbrosin - Zinkamin - Tabletts containing cink
Melbrosin - Q-10 - Capsules containing Q-10
Melbrosin - Folamin plus - Combination of folic acid, vitamin B6, vitamin B12
Melbrosin - Selavital - Combination of selenium, beta-carotene, vitamin E, B2 and B3
Melbrosin - Selafortin (Distribution) - Tabletts contains selenium
Melbrosin - Sunsan - Cooling lotion with an anti-allergenic, anti-inflammatory and curative effect
(From www.melbrosin.de)
Melbrosin (DE) - DAOSiN
Melbrosin (DE) - menoflavon Produktlinie
Melbrosin (DE) - melbrosia
Melbrosin (DE) - melpromen
Melbrosin (DE) - Botoina
Melbrosin (DE) - Crescina
Melbrosin (DE) - Sikapur Produktlinie
Melbrosin (DE) - Celerit
Melbrosin (DE) - SlimCup
Melbrosin (DE) - melprotect propolis Produktlinie
Kudos - Hair Nutrient, Nails and Skin, PMS, Muscle Support, Kudos 24 Multi-active Age Management Complex, Q100 Multi Vit, Prenatal Nutrient Formula, Q200 Multi Vit, Antioxidant Nutrient, Vitamin B12 500mcg plus Folic, Vitamin B Complex 50mg, Vit C500mg Cal & Mag, Vitamin B6 25mg plus Zinc, Vit C plus Bioflavonoids 900mg, Vit E 200iu (134mg) dry, Cal-Mag-Zinc, chromium GTF, Iron 30mg Amino Acid, Magnesium & Potassium, Zinc 20mg Citrate, Zinc 50mg Gluconate, Digestive Enzymes, Acidophilus plus Bifidus, Coenzyme Q 10 40mg, Bone Density - Currently out of stock, Circuplex, Cranberry Complex, Eye Bright Formula, Glucosamine sulphate, Hair Nutrient Formula, Menoplex, Muscle-support Formula, Nails & Skin Nutrient Formula, PMS Formula, Livoplex, Soya Isoflavones, Amino Acid Complex, L-Arginine / L-Ornithine, L-Carnitine 250mg, L-Carnitine 250mg, L-Cysteine 500mg , L-Glutamine 500mg, L-Lysine 500mg, L-Methionine 500mg, Black Cohosh 900, Cats Claw 900mg, Devils Claws 900mg, Dong Quai 900mg, Echinacea 900mg, Feverfew 900mg, Ginkgo Biloba 900mg, Clensoplex, Korean Ginseng 900mg, Milk Thistle 900mg, Saw Palmetto 900mg, Siberian Ginseng 900mg, St. Johns Wort 900mg, Valerian 900mg, Maca 900mg, Rhodiola 900mg, Kudos 24, Caffeine - Energy Boost - Strip product, Zinc and Echinacea - Strip product, Slimthru, Anti Cellulite and Skin Firming
Antibiotic Products
Alfatil (Purchased outright from Tonipharm)
Alphexine (Purchased outright from Tonipharm)
Cephaclor (Purchased outright from Tonipharm)
Technologies
TABWRAP is a patented high-speed continuous process for wrapping tablets or caplets in an ingestible or edible film sheet.
FASTWRAP -
XLWRAP -
WAFERTAB is a drug delivery system that incorporates pharmaceutical actives into an ingestible film strip. The system provides rapid dissolution and release of actives when the strip comes into contact with saliva in the mouth.
SOLULEAVES technology is used to produce a range of oral delivery films that can incorporate active ingredients, colours and flavours, and dissolve rapidly on contact with saliva. (Ronflux, oral freshening strips).
SWOLLO technology provides a liquid-filled oral capsule dosage form to the pharmaceutical industry.
NROBE technology consists of a process, equipment and film to produce NROBE dosage forms. The active pharmaceutical ingredient and excipients are lightly compressed and enrobed between two films and sealed to provide a compacted, coated dosage form to the pharmaceutical industry*.
SEPTUM provides a flexible two format dose form in any combination of liquid/ liquid, liquid/ solid and solid/ solid ingredients.
FOAMBURST is a special variant of the SOLULEAVES technology where gas is introduced into the film during production. This results in a film with a honeycombed structure which dissolves rapidly giving a 'melt in the mouth' sensation. FOAMBURST can be used for drug delivery but has also attracted interest from food and confectionary manufacturers as a means of carrying and releasing flavours.
SOLUPOL is a novel method for delivering liquid dosage forms, especially to those who are unable to swallow
MELTUMS (TM)
Higher dosage, non-strip version of soluleaves, drug delivery to those who cannot swallow / geriatric/paediatric market - ADHD, Alzheimers, Parkinsons. SCP smoking cessation product. Nutritional supplement range to launch in EU abling technology during Q4 2008.
...
Major Partners / Collaborations.
Partner A
Tabwrap - Analgesia
Tabwrap - Cough and Cold
Soluleaves - Various
Partner B
Tabwrap - CNS (Rx)
Tabwrap - Analgesic (Consumer)
Partner C
Tabwrap - Anticounterfeiting system
Partner D
Tabwrap - Brand recognition and anticounterfeiting
Partner E
Tabwrap - CNS (patent extension)
Partner F
Tabwrap/Fastwrap - Analgesic (OTC)
Meltums - Minerals/vitamins/supplements
Meltums - Soar throat
Partner G
Solupol - Gastric Reflux
Soluleaves - GI
Meltums - Antacid
Named Partners
Zentiva a.s - Oradisc, Part owned by Sanofi Aventis - Solupol product (CIS and CEE), also seeking global partners for product. Market size $1bn.
Uluru - Oradisc, DBP149?, Oral pain release, Benzocaine slow release 1-1.5 hours, oncology, ulcers + dental market (later).
Barr-Pliva UK - Tabwrap - "partner and co-promote certain products using the Company's TabWrapTM" (RNS 13/9/07)
Farmasierra (via FMC for European Nrobe manufacture - still the case?)
FMC Magenta - Nrobe
Zentiva: GI (Gastro Intestinal) product in CEE region - i think that there were some significant revenue projections for this product. (RNS 30/10/06)
Perrigo - Status?
Merck-Serono, comprising TabWrapTM, FastWrapTM, SoluPolTM and MeltumsTM (female healthcare)
Inyx Group - Strategic Collaboration to commercialize Tabwrap
Licenses/Links
AD Pharma - Some products licensed by Dexo.
GSK/Pfizer - Some products licensed by Dexo (Italy)
Silver Eagle Labs http://www.silvereaglelabs.com/
Merck-Serono: agreement for partnering tabwrap, fastwrap, solupol and meltums for products in the area of female healthcare (19/6/07)
Unamed Partners
3 Global pharmaceuticals for multiple enabling systems.
Discusssions with 15 pahraceutical companies for partnering arrangements
http://investing.thisismoney.co.uk/cgi-bin/digitalcorporate/thisismoney/security.cgi?csi=52397&action=news&story_id=1370712&rns=1
[unknown partner]: Non exclusive EU rights for 2 unknown Meltums products plus DBP274 (GI) licensed (21/12/07). Meltums products include novel RX analgesic (21/12/07)
Nicotine strips: partners in Poland (10m packs in 2008), India and China (5/11/07). Receiving orders (21/12/07)
Leading pharma (Shire?): Alzheimer and dementia products licensed for significant initial payment and double digit royalties to a (21/12/07). Mdx retain manufacturing (21/12/07). Also obesity product licensed to same pharma as Alzheimer products (21/12/07)
Major US partner (Perrigo?): OTC Analgesic range (14/12/07) - mdx has given peak revenue projection for product range of $300m (this may include rx products via dexo and not just be from this partnership)
Film supply customer (16/10/07) - $5-6m/pa
DBP121 - Soluleaves - Preferred smoking cessation partner, pharmacokinetic study, H1 2008
CEE partner (Walmark?) and Middle East partner [unknown]: planning to launch Collunovar Oradisc product under partnership agreements in Eastern Europe and the Middle East (21/12/07)
[unknown major partner]: SCP agreement with preferred partner (5/11/07) - manufacturing said to be worth $50m/pa plus royalties
...
Distributors
OTC Products - Jamieson Laboratories (Canada and Far East - China, Hong Kong, Taiwan, Chile, Caribbean) (Jamieson work in 50 countries in total)
OTC - Walmark (Central Europe)
OTC, Tabwrap - Gesine DBP240 + another Tabwrap analgesic in 2008 (Paracetamol based), German pharmacy group + a leading supplier of OTC medicines in the U.S.
Walmark (including sales in 15,000 pharmacies) in Central Europe/CEE for Phytosulin(R), DAOsin(R) and Slimcup(R)/SlimThruTM.
Melbrosin - Boots, Tescos
Kudos - GNC (Pharmacy chain), Harrods, Farmacia (Selfridges) Mankind,+ other UK pharmacies
Cristers - Dexo product distributors
Slimthru - Lloyds, AAH, Alliance Unichem, Tree of Life,The Healthstore, Boots, Tesco (4/10/07) .
Slimtrhu - Gesine (germany pharmacy network initially 1000 pharmacies) selling tabwrap analgesics and intention to sell paediatric analgesic when launched.
Slimthru - LLiD (1500 pharmacies in Germany) selling Slimthru with intent to sell analgesics (16/10/07)
Jameison in Canada, China, Hong Kong, Taiwan, Chile and the Caribbean for Menoflavon, Phytosulin and DAOsin.(19/12/07)
CoAcS - Gulf Region
Non DBP121, unregistered Nicotine products - Soluleaves - Marketing partner for Poland, with potenital option for CIS/CEE, commencing early 2008
Non DBP121, unregistered Nicotine products - Soluleaves and Meltums - Chinese marketing partner - 2008
Non DBP121, unregistered Nicotine products - Soluleaves - Indian marketing partner + Some EU, no date given
http://www.meldexinternational.com/Our_Company/Press_~_Media_Centre/News/Latest_News/DBP121_nicotine_product_update/News.aspx?id=4136
Locations
150 Employees
London - UK - Pharma marketing & PLC - 10
Cambridge - UK - Development - 10
Paris - France - Sales Marketing & Development - 5, Reps 27
Milan - Italy - Sales & Marketing - 3, Reps 9
Berlin - Germany - Sales & Marketing 52 (Austria & Germany)
Vienna - Austria - Sales & Marketing See above
Tampa - Development & Production - 23
Kansas City - USA - Sales & Marketing - 5, Reps - 12
Dexo (France only 2005).
Dexo (Italy, US, UK, Germany - Tawrap launch).
Links
Meldex International - http://www.meldexinternational.com/
Melbrosin - http://www.melbrosin.com/
Melbrosin - http://www.melbrosin.de/
Dexo Pharma (US) - http://www.dexous.com/
http://www.slimthru.co.uk/
http://www.slimcup.com/
http://www.fmcmagenta.com/NRobe/tabid/145/Default.aspx
http://www.cristers.net/
http://www.jamiesonvitamins.com/
http://www.gesine.net/gesine/home/
http://www.farmasierra.com/html/e_farmasierra.html
http://www.crescentpharma.com/
http://www.coacs.com/services/Trading/TradingDflt.htm - Pharmaceutical distribution (Gulf regio)
http://www.inyxinc.com/
http://www.hl.com/main.asp?p=corp_hlhzuk - Houlihan Lokey (strategic advisers)
http://www.blisters.ltd.uk/ - Slimthru packaging
http://www.silvereaglelabs.com/ - Silver Eagle Labs
All of the above for 24p.if you do not hold any mdx shares you cannot voteif you do not vote your opinion is not valid.and what purpose would your opinion serve?If I supported Man. Citywhat would be the point of telling Alex Ferguson who to sign.unless it was some nobber like treblewide or gay boy potty or big fat bouncy castle owner al..in which case they would weaken the team and so give Man City an advantage for all my help..Moral of the analogy your help aint helpful..So fuck off!
This is what I own for my 41p shares you could own the same for 24p or would you rather move into financials or housing or retail or Ladbrokes and shorting is a dieing tradeI know what my best hedge would be.
Updated R&D pipeline
Product Therapeutic area Technology Development Pre-registration Launch Comments
Rx
DBP117 Migraine Soluleaves 2009/10 Bioequivalence study expected H1 08
DBP118 Anti-emesis Oradisc 2010 Clinicals in 2008, file using 505(b)(2)
DBP149 Oral pain Oradisc 2009 Filed in the UK end Nov 07, will go through MRP
DBP167 Breakthrough pain Solupol 2008/09 Filing in UK expected H2 07, US some time in 08
DBP192 Terminal agitation Solupol 2010 Still early stage development
DBP214 Antihistamine Soluleaves 2007 Accuhist Ultra Soluleaves
DBP215 Cough and cold Soluleaves 2007 Ah-Chew Ultra Soluleaves
DBP220 Pain Paediatric Solupol 2009 Filing H1 2008 with launch 2009
DBP222 Migraine Adult Solupol 2009 Filing H1 2008 with launch 2009
DBP224 Breakthrough pain TabWrap/FastWrap 2010 Filing H2 2008 launch expected 2010
DBP226 Pain Nrobe 2010 Filing H2 2008 launch expected 2010
DBP228 Pain Meltums 2011 Filing H1 2009 launch expected 2011
DBP230 Flu symptoms Sachet 2010 Filing H2 2008 launch expected 2010
DBP232 Flu symptoms TabWrap/FastWrap 2010 Filing H2 2008 launch expected 2010
OTC
DBP121 Smoking cessation Soluleaves 2009 PK studies with known comparators H1 08
To be launched in early 2008 in unregulated markets
DBP122 Smoking cessation Meltums 2009 Chewable lozenge
To be launched in early 2009 in unregulated markets
DBP130 Anti-diarrhoea Soluleaves 2010
DBP147 Local anaesthetic Soluleaves 2007 Launched in US, Filing expected H1 08 in EU under Collunovar brand
DBP211 Decongestant Soluleaves 2007 Launched in US, Filing expected H1 08 in EU.
DBP213 Cough suppressant Soluleaves 2007 Launched in US, Filing expected H1 08 in EU.
DBP216 Analgesic TabWrap 2007 Will launch in US end 2007
DBP240 Analgesic TabWrap 2007 Will launch in Germany end 2007
DBP241 Analgesic FastWrap 2009/10 Talking to possible global partners
DBP272 Gastric Reflux Solupol 2008 (EU) Combination product with antacid
DBP274 Gastric Reflux Solupol 2009 Liquid raft alone
DBP276 Gastric Reflux Solupol 2009 Chewable version of combination product
DBP278 Gastric Reflux Solupol 2009 Chewable version of liquid raft
DBP310 Analgesic FastWrap 2008/09 Will file H2 08 in EU - Launch US H2 08
DBP312 Analgesic TabWrap/FastWrap 2009 Analgesic with codeine. Will file H2 08
DBP314 Analgesic FastWrap 2008/09 With phenylephrine. Will file H2 08 in EU, Launch US H2 08
DBP350 Analgesic XLWrap 2009 Sustained release analgesic - filing H2 2008 EU
DBP351 Analgesic XLWrap 2009 Sustained release analgesic - filing H2 2008 EU
DBP352 Analgesic XLWrap 2009 Sustained release analgesic - filing H2 2008 EU
DBP355 Analgesic TabWrap 2009 Novel Analgesic/NSAID combination - filing H2 2008 Global
DBP356 Analgesic TabWrap 2009 Novel Analgesic/NSAID combination - filing H2 2008 Global
Co-development with partner
Development Programmes
DBP117 Anti-Migraine Soluleaves Prescription - revenues expected from deals early 2008, 3% of Triptan market c.f. 1-1.5% of $3.1bn market
DBP118 - Anti-emesis Oradisc Prescription
DBP121 Smoking Cessation Product Soluleaves
DBP121 - Smoking cessation Soluleaves 2009 PK studies with known comparators H1 08 [Delayed was PK studies H2 07] [OTC]
DBP122 Smoking cessation Meltums 2009 Chewable lozenge
DBP130 - Anti-Diarrhoea Soluleaves Pre-registration
DBP147 Local anaesthetic Soluleaves 2007 Launched in US, Filing expected H1 08 in EU under Collunovar brand
DBP149 - Oral pain Oradisc 2009 Filed in the UK end Nov 07, will go through MRP [New] [RX] (Benzocaine containing a bio-erodible patch)
DBP167 Breakthrough pain Solupol 2008/09 Filing in UK expected H2 07, US some time in 08
DBP192 Terminal agitation Solupol 2010 Still early stage development
DBP211 Decongestant Soluleaves 2007 Launched in US, Filing expected H1 08 in EU.
DBP213 Cough suppressant Soluleaves 2007 Launched in US, Filing expected H1 08 in EU.
DBP214 - Antihistamine Soluleaves 2007 Accuhist Ultra Soluleaves [Now Rx]
DBP215 - Cough and cold Soluleaves 2007 Ah-Chew Ultra Soluleaves USA [Now Rx]
DBP216 - Analgesic (Paracetamol) TabWrap Scale Up - (Germany, Gesine Launch 2008), Will launch in US end 2007
DBP220 - Pain Paediatric Solupol 2009 Filing H1 2008 with launch 2009 - To be launched in early 2008 in unregulated markets
DBP222 - Migraine Adult Solupol 2009 Filing H1 2008 with launch 2009 [Bought forward was 2011]
DBP224 - Breakthrough pain TabWrap/FastWrap 2010 Filing H2 2008 [launch expected 2010 Bought forward was 2011]
DBP226 - Pain Nrobe 2010 Filing H2 2008 launch expected 2010 [Bought forward was 2011]
DBP228 - Pain Meltums
DBP230 - Flu symptoms Sachet 2010 Filing H2 2008 [launch expected 2010 Bought forward was 2011]
DBP232 - Flu symptoms TabWrap/FastWrap 2010 Filing H2 2008 [launch expected 2010 Bought forward was 2011]
DBP240 - Tabwrap, Pain Relief - Ibuprofen (Germany, Gesine Launch) - 1000 pharmacies with Gesine and other groups [OTC], Will launch in Germany end 2007
DBP241 - Tabwrap/Fastwrap, Pain Relief (v. of DBP240, Performs significantly better than expected - gbl. partners,2009/10) [OTC]
DBP272 - Gastric Reflux Solupol 2008 (EU) Rocgel - Combo product with antacid. Partner product [OTC]
DBP274 - Gastric Reflux - Basic RocGel Global 2008/9 - Extension of territorial rights
DBP276 - Gastric Reflux - Chewable / Solupol??? RocGel Global 2008/9
DBP278 - Gastric reflux Solupol
DBP310 - Analgesic (DBP216 deriv, parcetamol) - basic FastWrap (Paracetamol) - Acc dev, Will file H2 08 in EU - Launch US H2 08
DBP312 - Analgesic - combo FastWrap (Paracetamol with decongestant)- With codeine? - Acc dev, Will file H2 08
DBP314 - Analgesic (DBP216 deriv, paracetamol) Cold & flu, with phenylephrine? FastWrap- [OTC] Acc dev, Will file H2 08 in EU, Launch US H2 08
DBP316 - Paracetamol (DBP216 deriv, paracetamol) with decongestant + antihistamine
DBP318 - Paracetamol (DBP216 deriv, paracetamol) with decongestant + cough suppressant
DBP320 - Non-Drowsy Day (DBP216 deriv, paracetamol) - Night Cold & Flu Combination
DBP350 - Analgesic XLWrap 2009 Sustained release analgesic - filing H2 2008 EU [OTC]
DBP351 - Analgesic XLWrap 2009 Sustained release analgesic - filing H2 2008 EU [OTC]
DBP352 - Analgesic XLWrap 2009 Sustained release analgesic - filing H2 2008 EU [OTC]
DBP355 - Analgesic TabWrap 2009 Novel Analgesic/NSAID combo - filing H2 2008 Global [partner product] [OTC]
DBP356 - Analgesic TabWrap 2009 Novel Analgesic/NSAID combo - filing H2 2008 Global [partner product] [OTC]
DBP404 - Modified DBP216, Paediatric, easy swallow, low dose tablet, rapid release.
DBP??? - Tabwrap - obesity - License agreement
DBP??? - Meltums - 3 Products for the treatment of Dementia and Alzheimers - License agreement
DBP??? - Meltums - novel nicotine-containing product ???
........
Current Products and known launched products.
Dexo - Hyposalix - Artificial saliva.
Dexo US - Ah Chew Suspension - 12-Hour Dosing for Sinusitus and Common Cold - http://www.dexous.com/ah_chew_suspension.asp
Dexo US - Ah Chew D Suspension
Dexo US - Ah Chew Syrup
Dexo US - Ah Chew Ultra Suspension
Dexo US - Ah Chew Ultra Tablets - Chewable, Allergic Rhinitis and Post-Nasal Drip Relief - http://www.dexous.com/ah_chew_ultra.asp
Dexo US - Dexodryl Chewable Tablets - Antihistamine - Drying Agent - http://www.dexous.com/dexodryl_tabs.asp
Dexo US - Dexodryl Suspension - Antihistamine - Drying Agent - http://www.dexous.com/dexodryl_susp.asp
Dexo US - EZ Spacer - http://www.dexous.com/ez_spacer.asp
Dexo US - EZ Spacer PedsPak - http://www.dexous.com/ez_spacer_peds_pak.asp
Dexo US - Omnihist II LA - Antihistamine/Decongestant Tablet with Drying Agent - http://www.dexous.com/omnihist_ii_la.asp
Dexo US - Sinutuss DM Tablets - Three way Sinusitis and Bronchitis relief- http://www.dexous.com/pdf/sinu_tuss_dm.pdf
Dexo US - Sinuvent PE - Decongestant and expectorant tablet - http://www.dexous.com/sinuvent_pe.asp
Dexo US - SymPak - Sinuvent/ Omnihist AM/PM Dose format - Cough and Cold - http://www.dexous.com/pdf/SymPak.pdf
Dexo US - SymPak PDX - Sinuvent/ Omnihist AM/PM Dose - Cough and Cold - Extended Relief - http://www.dexous.com/pdf/SymPak.pdf
Dexo France - Artisial
Dexo France - BI OROSTAL (Added 09.08.07)
Dexo France - CITRATE BETAINE
Dexo France - CLERIDIUM
Dexo France - Collunovar
Dexo France - CORTISAL
Dexo France - Dexef
Dexo France - Diacor
Dexo France - DIMEGAN
Dexo France - ELIXIR BONJEAN
Dexo France - Endium
EXTOVYL 12mg G gra Fl/60 (3225099)
HYDRALOR Pdr sbuv rydrat 10Sach/5,2g (7934674)
Dexo France - Inflaced
Dexo France - Magnespasmyl
Dexo France - MUCIPULGITE
Dexo France - MULKINE
Dexo France - NITRODEX CHRONULES
Dexo France - Ronflux - Nasal Spray - EU registered for Ronflux Nasal Spray as a medical device - partnering in EU and worlwide
Dexo France - Ronflux - Strip
Dexo France - Ronflux - Mouth Spray line extension (In development)
Dexo France - Trolovol
Dexo France - Rogel
Dexo France - SPIRONONE
Dexo France - Physiomycine
Dexo Italy - Ceporex
Dexo Italy - Tamoxifen
Dexo Italy - Gabbroral
Dexo Italy - Acyvir
Dexo Italy - Curoxim
Dexo Italy - Eusaprim
Dexo Italy - Lefcar
Dexo Italy - Flutamide
Dexo Italy - Semprex
Dexo Italy - Atox - Liver detoxicant - licensed from AD Pharma
Dexo Italy - Antiserol - Cholesterol - licensed from AD Pharma
Dexo Italy - Floract - Intestinal Flora - licensed from AD Pharma
Dexo Italy - (From Dexo France) Hypozalix - Artificial saliva
Dexo Italy - (From Dexo France) Ronflux - Snoring
Dexo Italy - (From Dexo France) Calme - Seratonin
Dexo Italy - (From Dexo France) Gel Circulatoire - Muscle cramps/rhenatic pains
Dexo GmBH Germany - DBP240, an ibuprofen TabWrap(TM) analgesic, being launched via Gesine + other pharmacy chains
Dexo GmBH Germany - DMP404, variant of paracetamol aimed specifically for the junior market, 2008 launch
Dexo BioGenerics - Crescent Pharma and Dexo BioPharm, anti depressants one of which is a melt-in-the-mouth version. Sales for these products are
anticipated to commence in Q1 2009. The UK market is estimated to be worth approximately 50m."
Dexo Products - Crescent deal (Niplad's find).
Aluminium Hydroxlde Tablets - (Marketing Authorization from Crescent Pharma)
Aspirin Dispersible Tablets - (Marketing Authorization from Crescent Pharma)
Captopril Tablets - (Marketing Authorization from Crescent Pharma)
Cold and Influenza Capsules - (Marketing Authorization from Crescent Pharma)
Mentholated Balsam Llnctus - (Marketing Authorization from Crescent Pharma)
2 Paracetamol and caffeine capsules - (Marketing Authorization from Crescent Pharma)
Propranolol Tablels lOmg - (Marketing Authorization from Crescent Pharma)
Ibuprofen Tablets - Dossier Data (From Crescent Pharma)
Paracetamol Tablets - Dossier Data (From Crescent Pharma)
Codeine Tablets - Dossier Data (From Crescent Pharma)
Dlphenhydramine Tablets - Dossier Data (From Crescent Pharma)
Amoxicillin Capsules(for use excluding UK) - Dossier Data (From Crescent Pharma)
Amoxicillin Syrup (for use excluding UK) - Dossier Data (From Crescent Pharma)
Flucloxacillin Capsules (for use excluding UK) - Dossier Data (From Crescent Pharma)
Flucloxacillin Syrup (for use excluding UK) - Dossier Data (From Crescent Pharma)
Melbrosin (Own Products)
Melbrosin - menoflavon - menoflavon is a food supplement containing 40 mg isoflavones derived from standardised red clover extract.
Melbrosin - menoflavon forte -menoflavon forte, food supplement, isoflavones, red clover extract.
Melbrosin - menoflavon osteo - menoflavon osteo, food supplement, isoflavones, Calcium, Vitamin D3, Magnesium, Copper and Zinc.
Melbrosin - melbrosia -melbrosia - amino acids, oligopeptids, enzymes and flavonoids.
Melbrosin - melprotect propolis - care and protection of V-zone.
Melbrosin - melpromen - The bee products contained in melpromen - combination of potent topical agents, vitamins, and nutrients
Melbrosin - melpromen with Ginseng
Melbrosin - androflavon - androflavon, dietetic food containing red clover extract, selenium, vitamin E and vitamin D3.
Melbrosin - melbrodent Propolis-Gel - melbrodent Propolis-Gel, inflammation and infections of gums and mucous membranes.
Melbrosin - melbrodent Propolis Toothpaste - melbrodent Propolis Toothpaste, antibacterial.
Melbrosin - melbrosept Propolis Tincture & Spray - melbrosept Propolis Tincture & Spray - spray, drops, mouthwash or skin tonic.
Melbrosin - melbroderm - melbroderm propolis salve has anti-inflammatory and anti-rheumatic effects.
Melbrosin - Phytosulin - Insulin resistance - New product
Melbrosin - DAOsin(R) - Histamine intolerance - New Product
(Distribution Products)
Melbrosin - Imedeen is an unique top-quality skin care product
Melbrosin - SlimCup - SlimCup is a new and innovative concept for nutrition and weight management. New flavours, Feb 2008
Melbrosin - Botoina -Botoina is a special cosmetic for the relaxation of facial wrikles
Melbrosin - Crescina
Melbrosin - Labo
Melbrosin - Ladival - Individual sun protection and care for every one.
Melbrosin - Grippostad - cold symptoms such as headache, temperature and coughs.
Melbrosin - marplus -A nose spray for dry, sensitive and running noses.
Melbrosin - Bilatin -Bilatin Omega-3 fish oil capsules, arteriosclerosis, cholesterol regulation, rheumatism, heart attacks.
Melbrosin - Bilatin forte -Bilatin forte omega-3 fish oil capsules with pure natural fish oil.
Melbrosin - AciclostadMelbrosin - Aciclostad herpes cream 2g, active ingredient Aciclovir.
Melbrosin - Apotheker's Echte Hustenbonbons - High quality cough drops.
Melbrosin - Wellness line - Products for well being
Melbrosin - Etocovit - Capsules with natural Vitamin E
Melbrosin - Selamin - Tablets containing selenium
Melbrosin - Selamin plus - A combination of selenium and copper
Melbrosin - Melbrosin - Selamin-E - A combination of selenium and vitamin E
Melbrosin - Melbrosin - Sinusol - for cattarhal affections of the respiratory tract
Melbrosin - Zinkamin - Tabletts containing cink
Melbrosin - Q-10 - Capsules containing Q-10
Melbrosin - Folamin plus - Combination of folic acid, vitamin B6, vitamin B12
Melbrosin - Selavital - Combination of selenium, beta-carotene, vitamin E, B2 and B3
Melbrosin - Selafortin (Distribution) - Tabletts contains selenium
Melbrosin - Sunsan - Cooling lotion with an anti-allergenic, anti-inflammatory and curative effect
(From www.melbrosin.de)
Melbrosin (DE) - DAOSiN
Melbrosin (DE) - menoflavon Produktlinie
Melbrosin (DE) - melbrosia
Melbrosin (DE) - melpromen
Melbrosin (DE) - Botoina
Melbrosin (DE) - Crescina
Melbrosin (DE) - Sikapur Produktlinie
Melbrosin (DE) - Celerit
Melbrosin (DE) - SlimCup
Melbrosin (DE) - melprotect propolis Produktlinie
Kudos - Hair Nutrient, Nails and Skin, PMS, Muscle Support, Kudos 24 Multi-active Age Management Complex, Q100 Multi Vit, Prenatal Nutrient Formula, Q200 Multi Vit, Antioxidant Nutrient, Vitamin B12 500mcg plus Folic, Vitamin B Complex 50mg, Vit C500mg Cal & Mag, Vitamin B6 25mg plus Zinc, Vit C plus Bioflavonoids 900mg, Vit E 200iu (134mg) dry, Cal-Mag-Zinc, chromium GTF, Iron 30mg Amino Acid, Magnesium & Potassium, Zinc 20mg Citrate, Zinc 50mg Gluconate, Digestive Enzymes, Acidophilus plus Bifidus, Coenzyme Q 10 40mg, Bone Density - Currently out of stock, Circuplex, Cranberry Complex, Eye Bright Formula, Glucosamine sulphate, Hair Nutrient Formula, Menoplex, Muscle-support Formula, Nails & Skin Nutrient Formula, PMS Formula, Livoplex, Soya Isoflavones, Amino Acid Complex, L-Arginine / L-Ornithine, L-Carnitine 250mg, L-Carnitine 250mg, L-Cysteine 500mg , L-Glutamine 500mg, L-Lysine 500mg, L-Methionine 500mg, Black Cohosh 900, Cats Claw 900mg, Devils Claws 900mg, Dong Quai 900mg, Echinacea 900mg, Feverfew 900mg, Ginkgo Biloba 900mg, Clensoplex, Korean Ginseng 900mg, Milk Thistle 900mg, Saw Palmetto 900mg, Siberian Ginseng 900mg, St. Johns Wort 900mg, Valerian 900mg, Maca 900mg, Rhodiola 900mg, Kudos 24, Caffeine - Energy Boost - Strip product, Zinc and Echinacea - Strip product, Slimthru, Anti Cellulite and Skin Firming
Antibiotic Products
Alfatil (Purchased outright from Tonipharm)
Alphexine (Purchased outright from Tonipharm)
Cephaclor (Purchased outright from Tonipharm)
Technologies
TABWRAP is a patented high-speed continuous process for wrapping tablets or caplets in an ingestible or edible film sheet.
FASTWRAP -
XLWRAP -
WAFERTAB is a drug delivery system that incorporates pharmaceutical actives into an ingestible film strip. The system provides rapid dissolution and release of actives when the strip comes into contact with saliva in the mouth.
SOLULEAVES technology is used to produce a range of oral delivery films that can incorporate active ingredients, colours and flavours, and dissolve rapidly on contact with saliva. (Ronflux, oral freshening strips).
SWOLLO technology provides a liquid-filled oral capsule dosage form to the pharmaceutical industry.
NROBE technology consists of a process, equipment and film to produce NROBE dosage forms. The active pharmaceutical ingredient and excipients are lightly compressed and enrobed between two films and sealed to provide a compacted, coated dosage form to the pharmaceutical industry*.
SEPTUM provides a flexible two format dose form in any combination of liquid/ liquid, liquid/ solid and solid/ solid ingredients.
FOAMBURST is a special variant of the SOLULEAVES technology where gas is introduced into the film during production. This results in a film with a honeycombed structure which dissolves rapidly giving a 'melt in the mouth' sensation. FOAMBURST can be used for drug delivery but has also attracted interest from food and confectionary manufacturers as a means of carrying and releasing flavours.
SOLUPOL is a novel method for delivering liquid dosage forms, especially to those who are unable to swallow
MELTUMS (TM)
Higher dosage, non-strip version of soluleaves, drug delivery to those who cannot swallow / geriatric/paediatric market - ADHD, Alzheimers, Parkinsons. SCP smoking cessation product. Nutritional supplement range to launch in EU abling technology during Q4 2008.
...
Major Partners / Collaborations.
Partner A
Tabwrap - Analgesia
Tabwrap - Cough and Cold
Soluleaves - Various
Partner B
Tabwrap - CNS (Rx)
Tabwrap - Analgesic (Consumer)
Partner C
Tabwrap - Anticounterfeiting system
Partner D
Tabwrap - Brand recognition and anticounterfeiting
Partner E
Tabwrap - CNS (patent extension)
Partner F
Tabwrap/Fastwrap - Analgesic (OTC)
Meltums - Minerals/vitamins/supplements
Meltums - Soar throat
Partner G
Solupol - Gastric Reflux
Soluleaves - GI
Meltums - Antacid
Named Partners
Zentiva a.s - Oradisc, Part owned by Sanofi Aventis - Solupol product (CIS and CEE), also seeking global partners for product. Market size $1bn.
Uluru - Oradisc, DBP149?, Oral pain release, Benzocaine slow release 1-1.5 hours, oncology, ulcers + dental market (later).
Barr-Pliva UK - Tabwrap - "partner and co-promote certain products using the Company's TabWrapTM" (RNS 13/9/07)
Farmasierra (via FMC for European Nrobe manufacture - still the case?)
FMC Magenta - Nrobe
Zentiva: GI (Gastro Intestinal) product in CEE region - i think that there were some significant revenue projections for this product. (RNS 30/10/06)
Perrigo - Status?
Merck-Serono, comprising TabWrapTM, FastWrapTM, SoluPolTM and MeltumsTM (female healthcare)
Inyx Group - Strategic Collaboration to commercialize Tabwrap
Licenses/Links
AD Pharma - Some products licensed by Dexo.
GSK/Pfizer - Some products licensed by Dexo (Italy)
Silver Eagle Labs http://www.silvereaglelabs.com/
Merck-Serono: agreement for partnering tabwrap, fastwrap, solupol and meltums for products in the area of female healthcare (19/6/07)
Unamed Partners
3 Global pharmaceuticals for multiple enabling systems.
Discusssions with 15 pahraceutical companies for partnering arrangements
http://investing.thisismoney.co.uk/cgi-bin/digitalcorporate/thisismoney/security.cgi?csi=52397&action=news&story_id=1370712&rns=1
[unknown partner]: Non exclusive EU rights for 2 unknown Meltums products plus DBP274 (GI) licensed (21/12/07). Meltums products include novel RX analgesic (21/12/07)
Nicotine strips: partners in Poland (10m packs in 2008), India and China (5/11/07). Receiving orders (21/12/07)
Leading pharma (Shire?): Alzheimer and dementia products licensed for significant initial payment and double digit royalties to a (21/12/07). Mdx retain manufacturing (21/12/07). Also obesity product licensed to same pharma as Alzheimer products (21/12/07)
Major US partner (Perrigo?): OTC Analgesic range (14/12/07) - mdx has given peak revenue projection for product range of $300m (this may include rx products via dexo and not just be from this partnership)
Film supply customer (16/10/07) - $5-6m/pa
DBP121 - Soluleaves - Preferred smoking cessation partner, pharmacokinetic study, H1 2008
CEE partner (Walmark?) and Middle East partner [unknown]: planning to launch Collunovar Oradisc product under partnership agreements in Eastern Europe and the Middle East (21/12/07)
[unknown major partner]: SCP agreement with preferred partner (5/11/07) - manufacturing said to be worth $50m/pa plus royalties
...
Distributors
OTC Products - Jamieson Laboratories (Canada and Far East - China, Hong Kong, Taiwan, Chile, Caribbean) (Jamieson work in 50 countries in total)
OTC - Walmark (Central Europe)
OTC, Tabwrap - Gesine DBP240 + another Tabwrap analgesic in 2008 (Paracetamol based), German pharmacy group + a leading supplier of OTC medicines in the U.S.
Walmark (including sales in 15,000 pharmacies) in Central Europe/CEE for Phytosulin(R), DAOsin(R) and Slimcup(R)/SlimThruTM.
Melbrosin - Boots, Tescos
Kudos - GNC (Pharmacy chain), Harrods, Farmacia (Selfridges) Mankind,+ other UK pharmacies
Cristers - Dexo product distributors
Slimthru - Lloyds, AAH, Alliance Unichem, Tree of Life,The Healthstore, Boots, Tesco (4/10/07) .
Slimtrhu - Gesine (germany pharmacy network initially 1000 pharmacies) selling tabwrap analgesics and intention to sell paediatric analgesic when launched.
Slimthru - LLiD (1500 pharmacies in Germany) selling Slimthru with intent to sell analgesics (16/10/07)
Jameison in Canada, China, Hong Kong, Taiwan, Chile and the Caribbean for Menoflavon, Phytosulin and DAOsin.(19/12/07)
CoAcS - Gulf Region
Non DBP121, unregistered Nicotine products - Soluleaves - Marketing partner for Poland, with potenital option for CIS/CEE, commencing early 2008
Non DBP121, unregistered Nicotine products - Soluleaves and Meltums - Chinese marketing partner - 2008
Non DBP121, unregistered Nicotine products - Soluleaves - Indian marketing partner + Some EU, no date given
http://www.meldexinternational.com/Our_Company/Press_~_Media_Centre/News/Latest_News/DBP121_nicotine_product_update/News.aspx?id=4136
Locations
150 Employees
London - UK - Pharma marketing & PLC - 10
Cambridge - UK - Development - 10
Paris - France - Sales Marketing & Development - 5, Reps 27
Milan - Italy - Sales & Marketing - 3, Reps 9
Berlin - Germany - Sales & Marketing 52 (Austria & Germany)
Vienna - Austria - Sales & Marketing See above
Tampa - Development & Production - 23
Kansas City - USA - Sales & Marketing - 5, Reps - 12
Dexo (France only 2005).
Dexo (Italy, US, UK, Germany - Tawrap launch).
Links
Meldex International - http://www.meldexinternational.com/
Melbrosin - http://www.melbrosin.com/
Melbrosin - http://www.melbrosin.de/
Dexo Pharma (US) - http://www.dexous.com/
http://www.slimthru.co.uk/
http://www.slimcup.com/
http://www.fmcmagenta.com/NRobe/tabid/145/Default.aspx
http://www.cristers.net/
http://www.jamiesonvitamins.com/
http://www.gesine.net/gesine/home/
http://www.farmasierra.com/html/e_farmasierra.html
http://www.crescentpharma.com/
http://www.coacs.com/services/Trading/TradingDflt.htm - Pharmaceutical distribution (Gulf regio)
http://www.inyxinc.com/
http://www.hl.com/main.asp?p=corp_hlhzuk - Houlihan Lokey (strategic advisers)
http://www.blisters.ltd.uk/ - Slimthru packaging
http://www.silvereaglelabs.com/ - Silver Eagle Labs
All of the above for 24p.if you do not hold any mdx shares you cannot voteif you do not vote your opinion is not valid.and what purpose would your opinion serve?If I supported Man. Citywhat would be the point of telling Alex Ferguson who to sign.unless it was some nobber like treblewide or gay boy potty or big fat bouncy castle owner al..in which case they would weaken the team and so give Man City an advantage for all my help..Moral of the analogy your help aint helpful..So fuck off!
kimoldfield
- 24 Sep 2008 08:52
- 2849 of 8631
Morning Tabby, there's no denying MDX have an excellent R&D pipeline but the important stuff for investors will come out next Tuesday. Let's hope there's no need for these eh?! :- DBP130 - Anti-Diarrhoea Soluleaves
ptholden
- 24 Sep 2008 09:29
- 2850 of 8631
Clearly you have bought at totally the wrong times Tabbytwat, even more so since you claim to avergaing down :) Your six figure 'investment' is by definition showing at least a 45,000 loss!!! You are certainly a wise man and one to follow - ummm, I think not. (PS when are you going to admit you're still reading my posts? ROFLMAO)
Dil
- 24 Sep 2008 09:41
- 2851 of 8631
5p
tabasco - 24 Sep 2008 09:58 - 2852 of 8631
Dil.If you have noticed I always distance you from the office boys and girls that de-ramp on this site [and other sitesI know] we spar and all's fair in love and warbut for once on a serious noteif there are no hidden nastieswhich I truly believe there wont bewhat would be your valuation right nowplease dont make an absurd remarkserious valuation please.
kimoldfield
- 24 Sep 2008 10:17
- 2853 of 8631
One thing I would really like to see next week is the announcement of a new CEO, one who really knows what he's doing and can actually do a good job of running the company. The Muppet show is over hopefully.
| About MoneyAM | Ts and Cs | Privacy Policy | Investment Warning | Content Standards | Corporate Solutions | Advertise With Us | Site Map | © 2025 MoneyAM |
Register now for FREE
Share Prices,
Stock Quotes,
Charts, Bulletin Boards, Indices, Watchlists, Portfolio, Market News, Research
or see our Premium Services including Level 2, Terminal and much more.
Follow us on Twitter